IOVANCE BIOTHERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Carlos, CA
SEC filing record 1 source field available
Fiscal year end
31 December
IOVANCE BIOTHERAPEUTICS, INC. has filed 1,025 SEC EDGAR filings since 29 Jan 2008

SEC filing history

Showing 601-625 of 998 matching filings.

Per page
25
Current page
25
CT ORDER File 001-36860

CT ORDER filing

Filing date
06 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
03 Apr 2017
Reporting date
22 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
31 Mar 2017
Reporting date
28 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
07 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
02 Mar 2017
Reporting date
27 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85384

SC 13G/A filing

Filing date
16 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85384

SC 13G/A

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85384

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85384

SC 13G filing

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85384

13G

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85384

SC 13G/A filing

Filing date
10 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85384

LION BIOTECHNOLOGIES, INC.

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85384

SC 13G filing

Filing date
07 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85384

SC 13G/A filing

Filing date
25 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-215320

EFFECT filing

Filing date
11 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-215320

S-3

Filing date
23 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36860

CT ORDER filing

Filing date
23 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
28 Nov 2016
Reporting date
23 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
16 Nov 2016
Reporting date
14 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Nov 2016
Reporting date
14 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-214567

S-8

Filing date
10 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
04 Nov 2016
Reporting date
04 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
03 Nov 2016
Reporting date
03 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .